Zhejiang Hisoar Pharmaceutical Co (SZSE:002099) Total Assets : ¥7,593 Mil (As of Mar. 2025)

View and export this data going back to 2006. Start your Free Trial

What is Zhejiang Hisoar Pharmaceutical Co Total Assets?

Zhejiang Hisoar Pharmaceutical Co's Total Assets for the quarter that ended in Mar. 2025 was ¥7,593 Mil.

During the past 12 months, Zhejiang Hisoar Pharmaceutical Co's average Total Assets Growth Rate was -3.70% per year. During the past 3 years, the average Total Assets Growth Rate was -1.60% per year. During the past 5 years, the average Total Assets Growth Rate was 3.50% per year. During the past 10 years, the average Total Assets Growth Rate was 5.70% per year.

During the past 13 years, Zhejiang Hisoar Pharmaceutical Co's highest 3-Year average Total Assets Growth Rate was 43.90%. The lowest was -1.60%. And the median was 11.90%.

Total Assets is connected with ROA %. Zhejiang Hisoar Pharmaceutical Co's annualized ROA % for the quarter that ended in Mar. 2025 was 0.49%. Total Assets is also linked to Revenue through Asset Turnover. Zhejiang Hisoar Pharmaceutical Co's Asset Turnover for the quarter that ended in Mar. 2025 was 0.06.

Zhejiang Hisoar Pharmaceutical Co Total Assets Historical Data

The historical data trend for Zhejiang Hisoar Pharmaceutical Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Hisoar Pharmaceutical Co Total Assets Chart

Zhejiang Hisoar Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Assets

Get a 7-Day Free Trial

7,204.86

8,019.94

8,393.10

7,520.09

7,456.04

Zhejiang Hisoar Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Assets	Get a 7-Day Free Trial															7,650.43	7,632.07	7,609.93	7,456.04	7,592.94

Zhejiang Hisoar Pharmaceutical Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Zhejiang Hisoar Pharmaceutical Co's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Assets	=	Total Equity (A: Dec. 2024 )	+	Total Liabilities (A: Dec. 2024 )
	=	5131.831	+	2324.214
	=	7,456

Zhejiang Hisoar Pharmaceutical Co's Total Assets for the quarter that ended in Mar. 2025 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2025 )	+	Total Liabilities (Q: Mar. 2025 )
	=	5140.144	+	2452.798
	=	7,593

Zhejiang Hisoar Pharmaceutical Co (SZSE:002099) Total Assets Explanation

Total Assets is connected with ROA %.

Zhejiang Hisoar Pharmaceutical Co's annualized ROA % for the quarter that ended in Mar. 2025 is

ROA %	=	Net Income (Q: Mar. 2025 )	/	( (Total Assets (Q: Dec. 2024 )	+	Total Assets (Q: Mar. 2025 ))	/ count )
	=	36.92	/	( (7456.044	+	7592.942)	/ 2 )
	=	36.92	/	7524.493
	=	0.49 %

Note: The Net Income data used here is four times the quarterly (Mar. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Zhejiang Hisoar Pharmaceutical Co's Asset Turnover for the quarter that ended in Mar. 2025 is

	Asset Turnover
=	Revenue (Q: Mar. 2025 )	/	( (Total Assets (Q: Dec. 2024 )	+	Total Assets (Q: Mar. 2025 ))	/ count )
=	486.433	/	( (7456.044	+	7592.942)	/ 2 )
=	486.433	/	7524.493
=	0.06

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Zhejiang Hisoar Pharmaceutical Co Total Assets Related Terms

Thank you for viewing the detailed overview of Zhejiang Hisoar Pharmaceutical Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Hisoar Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Hisoar Pharmaceutical Co Ltd (SZSE:002099) » Definitions » Total Assets

Traded in Other Exchanges

N/A

Address

No. 507 Shifu Avenue, Taizhou International Business Plaza, Block A, 8F, Taizhou, Zhejiang, CHN, 318000

Website

http://www.hisoar.com

Zhejiang Hisoar Pharmaceutical Co Ltd is a China-based company engages in the production of specialty raw materials, preparations and fine chemicals, dyes and dye intermediates. Its products include Clindamycin hydrochloride, Clindamycin phosphate, Florfenicol, Atova, Thiamphenicol, and Riglinay.

Executives

Wang Yang Chao	Director
Yang Si Wei	Directors, executives
Xu Guo Rui	Executives
Xu Hua Qing	Secretary Dong
Hong Ming	Director
Guo Min Long	Director
Li Hong Ming	Executives
Jiang Ru Dong	Securities Affairs Representative
Mao Wen Hua	Executives
Sun Yang	Director
Li Wei Jin	Director
Luo Yu Hong	Director
Pan Qing Hua	Directors, executives
Chen Zheng Hua	Supervisors
Jia Qiang	Executives, directors

Zhejiang Hisoar Pharmaceutical Co Headlines

No Headlines